Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats

Experimental Neurology

Volumn 201, Issue 2, 2006, Pages 470-478

  Noh, Mi Ra ^a   Kim, Sung Koo ^b,c   Sun, Woong ^a   Park, Soon Kwon ^a   Choi, Hyung Chol ^a,b   Lim, Ji Hyae ^b   Kim, Il Hwan ^a   Kim, Hyun Ju ^a   Kim, Hyun ^a   Eun, Baik Lin ^b  

^a Department of Anatomy   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

Author keywords

AMPA; Cerebral ischemia; Neuroprotection; Newborn; Oxygen glucose deprivation; Topiramate

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; ANTICONVULSIVE AGENT; GAMMA GLUTAMYLAMINOMETHYLSULFONIC ACID; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; OXYGEN; TOPIRAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN OXYGEN CONSUMPTION; CELL DAMAGE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; GLUCOSE BRAIN LEVEL; NERVE CELL; NEUROPROTECTION; NEWBORN; NEWBORN MORTALITY; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PERINATAL MORBIDITY; PRIORITY JOURNAL; RAT; RISK FACTOR;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ADMINISTRATION, ORAL; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FRUCTOSE; HYPOXIA-ISCHEMIA, BRAIN; INJECTIONS, INTRAPERITONEAL; MAZE LEARNING; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 33748413906     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.04.038     Document Type: Article

References (44)

1. Angehagen M., Ben-Menachem E., Ronnback L., and Hansson E. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and TPM. Neurochem. Res. 28 (2003) 333-340
2. Angehagen M., Ben-Menachem E., Ronnback L., and Hansson E. TPM protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures. Epilepsy Res. 54 (2003) 63-71
3. Bahn S., Volk B., and Wisden W. Kainate receptor gene expression in the developing rat brain. J. Neurosci. 14 (1994) 5525-5547
4. Bourgeois B.F. Pharmacokinetics and metabolism of TPM. Drugs Today (Barc.) 35 (1999) 43-48
5. Calabresi P., Cupini L.M., Centonze D., Pisani F., and Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann. Neurol. 53 (2003) 693-702
6. Chang S., and De Camilli P. Glutamate regulates actin-based motility in axonal filopodia. Nat. Neurosci. 4 (2001) 787-793
7. Choi D.W. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. Prog. Brain Res. 96 (1993) 137-143
8. Dodgson S.J., Shank R.P., and Maryanoff B.E. TPM as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41 Suppl. 1 (2000) S35-S39
9. Edmonds Jr. H.L., Jiang Y.D., Zhang P.Y., and Shank R. TPM as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci. 69 (2001) 2265-2277
10. Glier C., Dziekto M., Bittigau P., Jarosz B., Korobowicz E., and Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp. Neurol. 187 (2004) 403-409
11. Gryder D.S., and Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by TPM in rat basolateral amygdala neurons. J. Neurosci. 23 (2003) 7069-7074
12. Herlenius E., and Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp. Neurol. 190 Suppl. 1 (2004) S8-S21
13. Hoover R.C., Motta M., Davis J., Saatman K.E., Fujimoto S.T., Thompson H.J., Stover J.F., Dichter M.A., Twyman R., White H.S., and McIntosh T.K. Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats. J. Neurotrauma 21 (2004) 501-512
14. Jakowec M.W., Jackson-Lewis V., Chen X., Langston J.W., and Przedborski S. The postnatal development of AMPA receptor subunits in the basal ganglia of the rat. Dev. Neurosci. 20 (1998) 19-33
15. Johnston M.V., Trescher W.H., Ishida A., and Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49 (2001) 735-741
16. Ikonomidou C., Mosinger J.L., Salles K.S., Labruyere J., and Olney J.W. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9 (1989) 2809-2818
17. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
18. Kim I.H., Park S.K., Sun W., Kang Y., Kim H.T., and Kim H. Spatial learning enhances the expression of inositol 1,4,5-trisphosphate 3-kinase A in the hippocampal formation of rat. Brain Res. Mol. Brain Res. 124 (2004) 12-19
19. Koh S., Tibayan F.D., Simpson J.N., and Jensen F.E. NBQX or TPM treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45 (2004) 569-575
20. Kudin A.P., Debska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 (2004) 1478-1487
21. Lee S.R., Kim S.P., and Kim J.E. Protective effect of TPM against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci. Lett. 281 (2000) 183-186
22. Liu Y., Barks J.D., Xu G., and Silverstein F.S. TPM extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35 (2004) 1460-1465
23. Marini A.M., Choi J., and Labutta R. Synaptic deprivation and age-related vulnerability to hypoxic-ischemic neuronal injury. A hypothesis. Ann. N. Y. Acad. Sci. 939 (2001) 238-253
24. McDonald R.J., and White N.M. Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav. Neural Biol. 61 (1994) 260-270
25. Metin C., Denizot J.P., and Ropert N. Intermediate zone cells express calcium-permeable AMPA receptors and establish close contact with growing axons. J. Neurosci. 20 (2000) 696-708
26. Metzger F., Wiese S., and Sendtner M. Effect of glutamate on dendritic growth in embryonic rat motoneurons. J. Neurosci. 18 (1998) 1735-1742
27. Montanez S., Kline A.E., Selwyn A.P., Suozzi J.C., Butler S.E., and Hernandez T.D. Vigabatrin directed against kindled seizures following cortical insult: impact on epileptogenesis and somatosensory recovery. J. Neurotrauma 18 (2001) 1255-1266
28. Monyer H., Burnashev N., Laurie D.J., Sakmann B., and Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 (1994) 529-540
29. Pagliusi S.R., Gerrard P., Abdallah M., Talabot D., and Catsicas S. Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons?. Neuroscience 61 (1994) 429-433
30. Penning D.H., Patrick J., Jimmo S., and Brien J.F. Release of glutamate and gamma-aminobutyric acid in the ovine fetal hippocampus: ontogeny and effect of hypoxia. J. Dev. Physiol. 16 (1991) 301-307
31. Poulsen C.F., Simeone T.A., Maar T.E., Smith-Swintosky V., White H.S., and Schousboe A. Modulation by TPM of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons. Neurochem. Res. 29 (2004) 275-282
32. Qian J., and Noebels J.L. TPM alters excitatory synaptic transmission in mouse hippocampus. Epilepsy Res. 55 (2003) 225-233
33. Rosenfeld W.E. TPM: a review of preclinical, pharmacokinetic, and clinical data. Clin. Therapeutics 19 (1997) 1294-1308
34. Schallert T., Hernandez T.D., and Barth T.M. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 379 (1986) 104-111
35. Shank R.P., Gardocki J.F., Vaught J.L., Davis C.B., Schupsky J.J., Raffa R.B., Dodgson S.J., Nortey S.O., and Maryanoff B.E. TPM: preclinical evaluation of structurally novel anticonvulsant. Epilepsia 35 (1994) 450-460
36. Shank R.P., Gardocki J.F., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of TPM: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 Suppl. 1 (2000) S3-S9
37. Skradski S., and White H.S. TPM blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41 Suppl. 1 (2000) S45-S47
38. Sun W., Funakoshi H., and Nakamura T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res. Mol. Brain Res. 103 (2002) 36-48
39. Uhm C.S., Kim K.B., Lim J.H., Pee D.H., Kim Y.H., Kim H., Eun B.L., and Tockgo Y.C. Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in rats. Neurosci. Lett. 353 (2003) 21-24
40. White H.S. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 38 Suppl. 1 (1997) S9-S17
41. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. TPM enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 28 (1997) 167-179
42. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179 (2000) 1-33
43. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. TPM modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 Suppl. 1 (2000) S17-S20
44. Yang Y., Shuaib A., Li Q., and Siddiqui M.M. Neuroprotection by delayed administration of TPM in a rat model of middle cerebral artery embolization. Brain Res. 804 (1998) 169-176